Review Article
Obesity, Visceral Fat, and NAFLD: Querying
the Role of Adipokines in the Progression of
Nonalcoholic Fatty Liver Disease
Table 6
Differences in adipocytokines expression between visceral and subcutaneous fat in humans [
28,
38,
49–
52,
57,
63–
67,
75].
| | Adipocytokine | Differences in expression |
| | Adiponectin | VF < SCF | | Adipsin | VF < SCF | | ASP | VF < SCF | | CETP | VF < SCF | | Leptin/Ob-Re | VF < SCF | | TNF-α | VF = SCF | | Angiotensinogen | VF > SCF | | Factor B | VF > SCF | | Il-6 | VF > SCF | | IL-8 | VF > SCF | | PAI-1 | VF > SCF | | PPAR-γ | VF > SCF | | Resistin | VF > SCF | | VEGF | VF > SCF | | 11β-HSD type 1 | VF > SCF | | MCP-1 | VF > SCF | | Visfatin | VF > SCF | | Omentin | VF > SCF |
|
|
11βHSD type 1: 11-hydroxy-steroid-dehydrogenase type 1; ASP: acylation stimulation protein; CETP: cholesterol ester transfer protein; IL-6: interleukin-6; IL-8: interleukin-8; PAI-1: plasminogen activator inhibitor-1; PPAR-γ: peroxisome proliferators-activated receptor-γ; SCF: subcutaneous fat; TNF-α: tumour necrosis factor-α; VF: visceral fat; VEGF, vascular endothelial growth factor; MCP-1: monocyte chemoattractant protein-1.
|
